40m series khosla

Synchron, a California-based company that develops neurostimulation devices for treating neurological disorders, has announced that it has raised $40 million in a Series B funding round led by Khosla Ventures. Other investors that participated in the round included General Catalyst, Mayo Clinic, and Morningside Ventures. synchron 40m series khosla. Synchron’s flagship product is the Stentrode, … Read more